Literature DB >> 25895585

Impact of global versus renal-specific sympathoinhibition in aldosterone-induced hypertension: implications for medical device-based treatment of resistant hypertension.

Casey Y Carmichael1, Richard D Wainford2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25895585      PMCID： PMC4433421          DOI： 10.1161/HYPERTENSIONAHA.115.05228

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  11 in total

1.  Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.

Authors:  George L Bakris; Mitra K Nadim; Hermann Haller; Eric G Lovett; Jill E Schafer; John D Bisognano
Journal:  J Am Soc Hypertens       Date:  2012-02-15

2.  Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Drew A Hildebrandt; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2005-10-10       Impact factor: 10.190

3.  Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.

Authors:  David E Kandzari; Deepak L Bhatt; Sandeep Brar; Chandan M Devireddy; Murray Esler; Martin Fahy; John M Flack; Barry T Katzen; Janice Lea; David P Lee; Martin B Leon; Adrian Ma; Joseph Massaro; Laura Mauri; Suzanne Oparil; William W O'Neill; Manesh R Patel; Krishna Rocha-Singh; Paul A Sobotka; Laura Svetkey; Raymond R Townsend; George L Bakris
Journal:  Eur Heart J       Date:  2014-11-16       Impact factor: 29.983

4.  Global- and renal-specific sympathoinhibition in aldosterone hypertension.

Authors:  Thomas E Lohmeier; Boshen Liu; Drew A Hildebrandt; Adam W Cates; Dimitrios Georgakopoulos; Eric D Irwin
Journal:  Hypertension       Date:  2015-04-20       Impact factor: 10.190

5.  Systemic and renal-specific sympathoinhibition in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Boshen Liu; Jeffrey R Henegar; Christine Maric-Bilkan; Eric D Irwin
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

6.  Arterial baroreceptors mediate the inhibitory effect of acute increases in arterial blood pressure on thirst.

Authors:  Sean D Stocker; Edward M Stricker; Alan F Sved
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-06       Impact factor: 3.619

Review 7.  Resistant hypertension and aldosterone: an update.

Authors:  Donald Clark; Mustafa I Ahmed; David A Calhoun
Journal:  Can J Cardiol       Date:  2012-04-21       Impact factor: 5.223

8.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

9.  Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.

Authors:  Murray D Esler; Michael Böhm; Horst Sievert; Christian L Rump; Roland E Schmieder; Henry Krum; Felix Mahfoud; Markus P Schlaich
Journal:  Eur Heart J       Date:  2014-06-04       Impact factor: 29.983

10.  Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex.

Authors:  Thomas E Lohmeier; Radu Iliescu; Terry M Dwyer; Eric D Irwin; Adam W Cates; Martin A Rossing
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-28       Impact factor: 4.733
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.